Drugs of Abuse Testing Assays
6-Acetylmorphine
AB-PINACA
- ARK AB-PINACA Assay
- Immunalysis Synthetic Cannabinoids-3 HEIA
Amphetamines
- Immunalysis Amphetamines HEIA
Barbiturates
- Immunalysis Barbiturates HEIA
Benzodiazepines
Benzoylecgonine (Cocaine Metab.)
- Immunalysis Benzoylecgonine HEIA
Buprenorphine
Cannabinoids
- Immunalysis Cannabinoids HEIA
Carisoprodol
- Immunalysis Carisoprodol HEIA
EDDP
- ARK EDDP Assay
- Immunalysis EDDP Specific HEIA
Ethylglucuronide (EtG)
Fentanyl
JWH-018
- ARK UR144/JWH-018 Assay
- Immunalysis Synthetic Cannabinoids-1 HEIA
Ketamine
Meperidine
- ARK Meperidine Assay
- Immunalysis Meperidine HEIA
Methamphetamine
- Immunalysis Methamphetamine HEIA
Methylphenidate-Metabolite
Opiates
- Immunalysis Opiates HEIA
Oxycodone
- Immunalysis Oxycodone HEIA
Phencyclidine (PCP)
- Immunalysis Phencyclidine HEIA
Pregabalin
Tapentadol
- Immunalysis Tapentadol HEIA
Tramadol
- ARK Diagnostics Tramadol Assay
- Immunalysis Tramadol HEIA
UR-144 / XLR-11
- ARK UR144/JWH-018 Assay
- Immunalysis Synthetic Cannabinoids-2 HEIA
Zolpidem
- Immunalysis Zolpidem HEIA
rFAB Ethylglucuronid (EtG) Assay
Thanks to its innovative recombinant FAB technology, the Ethyl Glucuronide Urine HEIA is a highly specific enzyme immunoassay for the precise determination of the alcohol metabolite ethyl glucuronide (EtG) in urine. FAB stands for ‘fragment antigen-binding’. This pioneering assay configuration is characterized by convincing performance and excellent specificity and selectivity.
Assay Characteristics
- Recombinant ethyl glucuronide antibody for consistent results
- More flexibility through dual cut-off – 500 ng/mL and 1,000 ng/mL
- Liquid, ready-to-use reagents, calibrators, and controls – no reconstitution required
- Application protocols for all major clinical chemistry analyzers
- Packaging tailored for your laboratory’s specific needs
Background
Ethyl glucuronide (EtG) is a direct ethanol metabolite formed by the liver’s enzymatic conjugation of ethanol and glucuronic acid. The detection of EtG in urine is a reliable indicator of recent alcohol exposure. EtG is formed when a person comes into contact with alcohol-containing products that enter the bloodstream. However, EtG assays do not provide an indication of the source of the ethanol.
While alcohol is only detectable briefly after consumption, an EtG assay offers a much wider detection window. It can be used to check alcohol consumption or to monitor abstinence. Other areas of application include alcohol withdrawal programs, the detection of alcohol abuse, patients before a liver transplant, pregnant women, drivers hoping to renew their driving licenses, and prisoners on probation.
Package Inserts